Financials
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 24 M27 M26 M26 M26 M27 M 105 M Research & development —————— — Operating income 812 M826 M715 M696 M1.47 B361 M 3.24 B Non-Operating Income, Total -189 M-185 M-162 M-190 M-182 M-175 M -709 M Interest expense, net of interest capitalized 197 M190 M188 M189 M186 M181 M 744 M Non-Operating Income, excl. Interest Expenses -189 M-185 M-372 M-380 M-369 M-357 M -1.48 B Unusual income/expense 0022 M1 M1 M1 M 25 M Pretax income 426 M451 M365 M317 M1.1 B5 M 1.79 B Equity in earnings —————— — Taxes —————— — Non-controlling/minority interest —————— — After tax other income/expense -3 M-4 M-5 M-10 M-7 M-5 M -27 M Net income before discontinued operations 623 M641 M553 M506 M1.29 B186 M 2.53 B Discontinued operations —————— — Net income 623 M641 M553 M506 M1.29 B186 M 2.53 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 511 M511 M511 M520 M520 M482 M 2.03 B Basic earnings per share (Basic EPS) —————— — Diluted earnings per share (Diluted EPS) —————— — Average basic shares outstanding —————— — Diluted shares outstanding —————— — EBITDA 983 M997 M886 M869 M1.64 B535 M 3.93 B EBIT 812 M826 M715 M696 M1.47 B361 M 3.24 B Cost of revenue 1.17 B1.7 B1.2 B1.28 B968 M2.76 B 6.2 B Other cost of goods sold 1.17 B1.7 B1.2 B1.28 B968 M2.76 B 6.2 B Depreciation & amortization (cash flow) 171 M171 M171 M173 M173 M174 M 691 M